Author

Caitlin Gee

University of California, Los Angeles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Dino Di CarloiD· 1 shared Donghui Cheng· 1 shared Heather Wright· 1 shared Jami McLaughlin· 1 shared Jeffrey D. Varner· 1 shared Jingyi Jessica LiiD· 1 shared Joseph A. Wayman· 1 shared Justin LangermaniD· 1 shared

Activity by Year

2016-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Dino Di CarloORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systematic mapping of emergent transcriptional states in interacting single-cell dyads by Cell-Cell-seq

Sevana Baghdasarian, Qingyang Wang, Justin Langerman, Zhiyuan Mao, Heather Wright, Caitlin Gee, Donghui Cheng, Jami McLaughlin, Lee Jc, Xiaojing Tina Chen, K. Christopher García, Jingyi Jessica Li, Owen N. Witte, Kathrin Plath, Dino Di Carlo

Cell-Cell-seq maps transcriptional states in interacting cell pairs by profiling defined dyads, revealing emergent gene programs and cross-cell coordination in tumor-T cell interactions.

bioRxiv · Feb 9, 2026 · PreprintBioengineering

Modeling and Analysis of Hormone and Mitogenic Signal Integration in Prostate Cancer

Katharine V. Rogers, Joseph A. Wayman, Ryan Tasseff, Caitlin Gee, Matthew P. DeLisa, Jeffrey D. Varner

This study uses mathematical models to analyze hormone and mitogenic signaling in prostate cancer, finding that combining inhibitors targeting multiple pathways improves efficacy against castration-resistant prostate cancer.

bioRxiv · Jun 13, 2016 · PreprintSystems Biology